comparemela.com

Latest Breaking News On - Professor jianzhong zhang - Page 1 : comparemela.com

Kintor Pharma Announces Completion of First Patient Enrollment in Long-term Safety Phase III Trial of KX-826 for Treatment of AGA

/PRNewswire/ Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and.

United statesKintor pharmaJianzhong zhangPrnewswire kintor pharmaceutical limited pharmaKintor pharmaceuticalUniversity people hospitalChina national medical products administrationPharmaceutical limitedLong term safety trialProfessor jianzhong zhangPeking university peopleLong term safety

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

DJ Kintor Pharma Announces 2022 Annual Results and Recent Business Progress EQS Newswire / 31/03/2023 / 10:10 UTC+8 Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

Hong kongKintor pharmaJianzhong zhangUniversity people hospitalInnovative pharmaceutical companiesKintor pharmaceutical limited pharmaSecurity department of guangdong provinceRapid progress on global clinical developmentInnovation companiesInnovative small molecule pharmaceutical companiesMost influential small molecule pharmaceutical innovation companiesMeeting of chinese hair research societyHong kong stock exchangeHong kong listed companiesPharma announcesRecent business progress

Kintor Pharma Announces 2022 Annual Results and -2-

DJ Kintor Pharma Announces 2022 Annual Results and Recent Business Progress EQS Newswire / 31/03/2023 / 10:10 UTC+8 Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

Hong kongKintor pharmaJianzhong zhangUniversity people hospitalInnovative pharmaceutical companiesMarketing pressKintor pharmaceuticalKintor pharmaceutical limited pharmaSecurity department of guangdong provinceRapid progress on global clinical developmentInnovation companiesInnovative small molecule pharmaceutical companiesHong kong listed companiesHong kong stock exchangeMost influential small molecule pharmaceutical innovation companiesMeeting of chinese hair research society

Kintor Pharmaceutical : Pharma Announces 2022 Annual Results and Recent Business Progress

Suzhou, March 30, 2023 - Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business. | March 30, 2023

Hong kongJianzhong zhangKintor pharmaInnovative small molecule pharmaceutical companiesHong kong stock exchangeRapid progress on global clinical developmentSecurity department of guangdong provinceInnovative pharmaceutical companiesHong kong listed companiesMeeting of chinese hair research societyUniversity people hospitalMost influential small molecule pharmaceutical innovation companiesKintor pharmaceutical limited pharmaInnovation companiesPharmaceutical limitedShanghai hong kong stock connect

Kintor Pharma Announces 2022 Annual Results and Recent Business Progress

SUZHOU, China, March 30, 2023 /PRNewswire/ Kintor Pharmaceutical Limited , a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today. | March 30, 2023

Hong kongJianzhong zhangKintor pharmaUniversity people hospitalHong kong stock exchangeInnovative pharmaceutical companiesMeeting of chinese hair research societyHong kong listed companiesInnovation companiesKintor pharmaceuticalPrnewswire kintor pharmaceutical limited pharmaRapid progress on global clinical developmentPharmaceutical limitedShanghai hong kong stock connectYouzhi tongGlobal clinical development

vimarsana © 2020. All Rights Reserved.